Perkins Capital Management »

Neuroone Med Technologies Corp shares owned by Perkins Capital Management

Quarter-by-quarter ownership of Neuroone Med Technologies Corp (NMTC) shares owned by Perkins Capital Management from 13F filings

Historical chart of Perkins Capital Management investment in Neuroone Med Technologies Corp

Tip: Access up to 7 years of quarterly data

All positions including Neuroone Med Technologies Corp held by Perkins Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuroone Med Technologies Corp by Perkins Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $237k 150k 1.58
2023-09-30 $134k 150k 0.89

More positions owned by Perkins Capital Management

Augmedix (AUGX)
Eli Lilly & Co. (LLY)
IDEXX Laboratories (IDXX)
Microsoft Corporation (MSFT)
Natera (NTRA)
Advanced Micro Devices (AMD)
Veracyte (VCYT)
Neogenomics Com New (NEO)
Quicklogic Corp Com New (QUIK)
Inuvo Com New (INUV)
Abbott Laboratories (ABT)
Alphatec Hldgs Com New (ATEC)
Axogen (AXGN)
Flexshopper Com New (FPAY)
LeMaitre Vascular (LMAT)

View all positions for Perkins Capital Management

Top funds holding Neuroone Med Technologies Corp

Nantahala Capital Management
Vanguard Group
Perkins Capital Management
MAI Wealth Advisors
Virtu Financial
Princeton Global Asset Management
Citadel Advisors
Centerpoint Advisors
UBS Group
Simplex Trading
Nemes Rush Group
Advisor Group Holdings
Wells Fargo & Company
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Neuroone Med Technologies Corp